Comparison of efficacy and safety of oral fluconazole and topical clotrimazole in the treatment of tinea corporis, tinea cruris, tinea pedis, and cutaneous candidiasis

Current Therapeutic Research - Clinical and Experimental

Volumn 59, Issue 7, 1998, Pages 503-510

  Crevits, Bart ^a   Picoto, Antonio ^b   Staberg, Bent ^c   Urbanowski, Slawomir ^d   Silny, Wojciech ^e  

^a GHENT UNIVERSITY HOSPITAL   (Belgium)

^b Medical Surgical Center of Dermatology   (Portugal)

^c Skin Clinic   (Denmark)

^d NICOLAUS COPERNICUS UNIVERSITY   (Poland)

^e POZNAN UNIVERSITY OF MEDICAL SCIENCES   (Poland)

Author keywords

Clotrimazole; Cutaneous candidiasis; Fluconazole; Tinea corporis; Tinea cruris; Tinea pedis

Indexed keywords

CLOTRIMAZOLE; FLUCONAZOLE;

ADOLESCENT; ADULT; AGED; ARTICLE; BRONCHOSPASM; CANDIDIASIS; CLINICAL TRIAL; DRUG EFFICACY; DRUG SAFETY; DRUG TOLERABILITY; FEMALE; FOLLOW UP; GASTROINTESTINAL SYMPTOM; HEADACHE; HUMAN; HYPERBILIRUBINEMIA; MAJOR CLINICAL STUDY; MALE; PARESTHESIA; PATIENT COMPLIANCE; PRIORITY JOURNAL; PRURITUS; TINEA CORPORIS; TINEA CRURIS; TINEA PEDIS; TREATMENT OUTCOME;

EID: 0031877436     PISSN: 0011393X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0011-393X(98)85087-X     Document Type: Article

References (8)

1. Brammer KW, Farrow PR, Faulkner JK, Pharmacokinetics and tissue penetration of fluconazole in humans. Rev Infect Dis. 1990;12(Suppl 3):S318-S326.
2. De Bersaques J, Bjerke JR, Borelli S, et al. Comparison of oral fluconazole and topical clotrimazole in the treatment of fungal infections of the skin: European and American experience. Int J Dermatol. 1992;31(Suppl 2):21-26.
3. Evans EGV, Gentles JC, eds. Essentials of Medical Mycology. New York: Churchill Livingstone; 1985:30-37.
4. Grant SM, Clissold SP. Fluconazole: A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in superficial and systemic mycoses. Drugs. 1990;39:877-916.
5. Suchil P, Montero Gei F, Robles R, et al. Once-weekly oral doses of fluconazole 150 mg in the treatment of tinea corporis/cruris and cutaneous candidiasis. Clin Exp Dermatol. 1992;17:397-401.
6. Del Aguila R, Montero Gei F, Robles R, et al. Once-weekly oral doses of fluconazole 150 mg in the treatment of tinea pedis. Clin Exp Dermatol. 1992;17:402-406.
7. Lewis JH, Zimmerman HJ, Benson GD, Ishak KG. Hepatic injury associated with ketoconazole therapy. Gastroenterology. 1984;86:503-513.
8. Faergemann J. Use of fluconazole in the treatment of human fungal infections of the skin: Introduction. Int J Dermatol. 1992;31(Suppl 2):1-2.